What is the price-to-earnings ratio of CSL?
The price-earnings ratio of CSL is currently 6.16.
CSL P/S 2024
CSL P/S
6.16
Ticker
CSL.AX
ISIN
AU000000CSL8
WKN
890952
As of Sep 21, 2024, CSL's P/S ratio stood at 6.16, a -17.87% change from the 7.5 P/S ratio recorded in the previous year.
The CSL P/S history
CSL Aktienanalyse
What does CSL do?
CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding CSL's P/S Ratio
CSL's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing CSL's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating CSL's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in CSL’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about CSL stock
How has the price-earnings ratio of CSL changed compared to last year?
The price-to-earnings ratio of CSL has increased by -17.87% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of CSL high compared to other companies?
Yes, the price-to-earnings ratio of CSL is high compared to other companies.
How does an increase in the price-earnings ratio of CSL affect the company?
An increase in the price-earnings ratio of CSL would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of CSL affect the company?
A decrease in the price-earnings ratio of CSL would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of CSL?
Some factors that influence the price-earnings ratio of CSL are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does CSL pay?
Over the past 12 months, CSL paid a dividend of 4 USD . This corresponds to a dividend yield of about 2 %. For the coming 12 months, CSL is expected to pay a dividend of 4.22 USD.
What is the dividend yield of CSL?
The current dividend yield of CSL is 2 %.
When does CSL pay dividends?
CSL pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of CSL?
CSL paid dividends every year for the past 26 years.
What is the dividend of CSL?
For the upcoming 12 months, dividends amounting to 4.22 USD are expected. This corresponds to a dividend yield of 2.11 %.
In which sector is CSL located?
CSL is assigned to the 'Health' sector.
Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CSL from 10/2/2024 amounting to 2.203 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.
When did CSL pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of CSL in the year 2023?
In the year 2023, CSL distributed 3.715 USD as dividends.
In which currency does CSL pay out the dividend?
The dividends of CSL are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The CSL stock can be added to a savings plan with the following providers: Consorsbank
Andere Kennzahlen von CSL
Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
